CVS HEALTH Corp
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)
Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%
Cvs Health Assumed Premiums Earned by Year
Assumed Premiums Earned ($M)
Cvs Health Assumed Premiums Earned: $573M in FY2025, up 21.7% from a year earlier.
Latest, FY2025
573
Period ended Dec 31, 2025
Change on a year earlier
+21.7%
471 in FY2024
History
8 years
Since FY2018
Sources
1
CVS SEC 10-K (XBRL us-gaap:AssumedPremiumsEarned)
Where the FY2025 figure comes from
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Assumed Premiums Earned ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 573 | +21.7% | CVS SEC 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗ |
| FY2024 | Dec 31, 2024 | 471 | +34.6% | CVS SEC 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗ |
| FY2023 | Dec 31, 2023 | 350 | -19.0% | CVS SEC 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗ |
| FY2022 | Dec 31, 2022 | 432 | -12.2% | CVS SEC 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗ |
| FY2021 | Dec 31, 2021 | 492 | +2.9% | CVS SEC 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗ |
| FY2020 | Dec 31, 2020 | 478 | -77.3% | CVS SEC 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗ |
| FY2019 | Dec 31, 2019 | 2,108 | +5,447.4% | CVS SEC 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗ |
| FY2018 | Dec 31, 2018 | 38 | – | CVS SEC 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗ |
Cite this data
StockData. (2026). Cvs Health Assumed Premiums Earned ($M), annual FY2018–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/premiums-assumed
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.